CorMedix Inc (CRMD)

7.26 +2.62%

CorMedix Inc (CRMD) is currently trading at $7.26. This represents a gain of 2.62% from the previous session. With a market capitalization of $0.57B, CRMD is a key component of the Health Care sector. Investors looking to trade CRMD should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade CRMD commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, CorMedix Inc (CRMD) shows a bullish trend. Analysts are watching the 7.31 level closely.

Fundamentals
Mkt Cap0.57B
P/E Ratio0.0000
Volume436,533
Others Watching (By Market Cap)
CNMD
Conmed Corp $46.03
-0.07% PGEN
Precigen Inc $3.86
-3.14% ORIC
ORIC Pharmaceut $13.35
-0.52% GLUE
Monte Rosa Ther $18.05
-6.14% CAPR
Capricor Therap $28.36
+1.45%
60-Day Technical Chart
Advanced Charting

Need more indicators for CRMD? Use the world's #1 platform.

Open CRMD on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $7
Metric CRMD
+2.62% 		ACHR
-0.76% 		LUMN
-4.90% 		QS
-0.43%
Price $7.26 $7.14 $7.09 $7.03
Mkt Cap $0.57B $4.68B $7.27B $4.25B
- View → View → View →
Latest Headlines
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings? Yahoo Finance • Feb 23, 2026 CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet? TradingView • Feb 24, 2026 CorMedix Therapeutics Announces Share Repurchase Program GlobeNewswire • Feb 2, 2026 Why Did CRMD Stock Crash 28% Today? Stocktwits • Jan 8, 2026 CorMedix stock falls after issuing 2026 revenue guidance Investing.com • Jan 8, 2026
● Gemini Agentic AI Analyst Insight for CRMD
Market Education
View All Articles →
External Research